Biomarkers Market By Type (Biomarker of Disease, Biomarker of Exposure), By Application (Disease Diagnosis, Disease Progression, Drug Discovery and Development, Development of Molecular Diagnostics, Forensic, Others), By End User (Hospitals, Research Organizations, Diagnostic Centers, Others)Â and Geography
Biomarkers Market size was valued at USD 42.1 billion in 2021 and is projected to reach USD 94.2 billion by 2028 at a CAGR of 12.2% during the forecast period 2022 to 2028. Biomarkers are cellular or molecular diagnostic tools, measured in in biological samples, for instance, urine, stool and blood. It is utilized as an indicator to check and assess biological, pharmacological and pathogenic procedures. Biomarkers range from proteins, lipids, carbohydrates, RNA, DNA, hormones, platelets etc. Currently wide range of biomarkers market are available for the different systems such as cardiovascular, metabolic system and immune system. Biomarkers not only help in diagnosis of the disease but also helps in tracking progression, regression and outcome after the intervention. Furthermore, biomarkers are also used in the drug development. Biomarkers of exposure and biomarkers of disease are the two major types of diagnostic biomarkers. Biomarkers of exposure are a new method for determining the quantity of harmful chemicals in a person's body. These biomarkers allow for the detection of aberrant activity and the calculation of the pre-disease state. Biomarkers of disease are used to identify disease conditions and to help validate clinical trials for new drugs. A perfect biomarker has specific qualities, such as being safe and easy to assess, being cost-effective to follow up on, and being changeable with treatment that is consistent across gender and ethnic groups. Biomarkers are used to predict serious illnesses like diabetes and cardiovascular disease, as well as cancer, neurological disorders, immunological disorders, and others. Every biomarker shows if a disease or a state of health exists, and they can be combined to give a complete picture of how healthy a person is and whether a diagnosis is required. Biomarkers are also employed in imaging technologies to give clear imaging of cancer tumours and other issues, as well as in clinical trials to identify the effect and effects of medications early on.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
biomarkers market primarily driven by rise in demand and need for the accurate diagnosis of disease and progression of the intervention due to the increase in diseases like cancer and cardiovascular diseases. In addition, initiatives taken by the government and market players in biomarker research coupled with increase in the number of clinical research organizations are expected to boost the market over the forecast period. Furthermore, expansion of the applications of biomarkers in drug development and diagnostic segments projected to propel the growth of market in near future. On the other hand, high cost of discovery and development, poor reimbursement policies and technical issues in sample collection may hamper the market growth over the forecast period.
Geographically, global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America projected to have dominated market for biomarkers owing to the increase in ageing population and diagnosis of age related diseases. Asia Pacific projected to have the lucrative opportunity of growth owing to the increase in the cardiovascular diseases and cancer cases. For instance, According to data of Ministry of Health, China, there were 203 million people are suffering from the cardiovascular diseases and is expected to increase 73% by 2030. Furthermore, market players interest in expansion of their companies to Asia Pacific region due to low cost of production. This is likely to positively impact the growth of market in this region. Europe market expected to have the notable growth rate owing to the presence of the key market players and increase in the prevalence of diseases in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
[urltag url='request-table-of-content']